Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
The 2020 Summer CMTA Report
…CMT Patients Turn to Telemedicine For Treatment During Pandemic Six Centers of Excellence Surveyed Connecting Our Community Online Taking the Toronto Branch Online Intubation and Mechanical Ventilation Calling All Dreamers!…
Sperm Donor with Gene for Charcot-Marie-Tooth Disease Passes It on to Multiple Families
…treatment for the painful and debilitating symptoms that CMT causes.” In a happy footnote to the Erica’s story, Frankie was recently accepted to Camp Footprint, the country’s only sleepaway camp…
SYNAPSE-CMT: Join the Journey to Advance CMT Research
…for people living with CMT. The hope is that this treatment will improve your strength, endurance, and overall daily functioning. By joining the study, you’ll play a critical role in…
A New Therapeutic Strategy for CMT2D
…for nerve cell survival. Through experiments that identified the cause of this transport disruption, the scientists were able to develop a treatment strategy that improves this critical transportation system in…
Nanoparticles for CMT1A, CMT1B, and CMTX1: A New Frontier in Gene Therapy
…cells while remaining capable of delivering the necessary gene therapies effectively. This delicate balance is crucial for the success of the treatment, as the nanoparticles must be able to traverse…
CMTA-STAR Alliance Partner NMD Pharma Publishes Transformative Study on Charcot-Marie-Tooth Disease
…According to the company, treatment with the company’s novel CIC-1 inhibitor NMD670 improved muscle function in preclinical models, marking a critical step toward developing therapies for the CMT community. “This…
Inherited Neuropathies Consortium Study 6611: Charcot-Marie-Tooth disease Infant Scale
…study, led by INC, aims to develop and validate the Charcot-Marie-Tooth Infant Scale (CMTInfS) to assess disease severity in infants and toddlers. Research suggests that treatment to slow disease progression…
CMTA Announces New Center of Excellence in Kentucky
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is excited…
Project Foresee: The Path to Cure CMT4C
…(see AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C). The results from this research provide the level of confidence needed by the best scientists,…
Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact
…the Health Sciences (USU). The paper, published in Cellular and Molecular Life Sciences, reports encouraging advancements in the search for treatments for CMT1A and CMT1B. Building on his previous CMTA-funded…